Literature DB >> 8553395

Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.

B Wildemann, C Schülin, B Storch-Hagenlocher, W Hacke, S Dithmar, K Kirchhof, O Jansen, A Breitbart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8553395

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

1.  Treatment of Susac Syndrome.

Authors:  Ivana Vodopivec; Sashank Prasad
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

2.  Neurological picture. Susac's syndrome: effective combination of immunosuppression and antiplatelet treatment.

Authors:  I Kleffner; E B Ringelstein; N Stupp; T-U Niederstadt; P Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12       Impact factor: 10.154

Review 3.  Characteristics of Susac syndrome: a review of all reported cases.

Authors:  Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

4.  Susac's Syndrome in a Patient Diagnosed with MS for 20 Years: A Case Report.

Authors:  Bijen Nazliel; Asli Akyol; Hale Zeynep Batur Caglayan; Irem Yildirim-Capraz; Ceyla Irkec
Journal:  Case Rep Neurol Med       Date:  2014-02-02

5.  Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.

Authors:  Sven Jarius; Ilka Kleffner; Jan M Dörr; Jaume Sastre-Garriga; Zsolt Illes; Eric Eggenberger; Colin Chalk; Marius Ringelstein; Orhan Aktas; Xavier Montalban; Kai Fechner; Winfried Stöcker; Erich B Ringelstein; Friedemann Paul; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2014-03-08       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.